Male pattern vs. female pattern hair loss
Here's something most people don't know: male and female pattern hair loss are driven by the exact same hormone. But they look nothing alike, and that difference is the reason women's hair loss so often goes unnoticed for years.
Two different patterns
In men, hair loss usually starts at the temples and moves back, or thins out at the crown, eventually meeting in the middle. This is mapped out on something called the Norwood scale, seven stages, and most people can picture it instantly. It's why "receding hairline" is such a recognisable phrase.
In women, it looks completely different. Instead of receding from the front, hair thins out evenly across the top and crown, like the part is slowly getting wider. The hairline itself usually stays put, even when the thinning is significant. This is mapped on the Ludwig scale, just three grades, and it's a much quieter, harder-to-spot pattern.
That one difference, hairline lost vs. hairline kept, is why the two look so different, even though the same hormone is behind both.
So what's actually causing it?
The hormone is DHT (dihydrotestosterone). Your body makes it from testosterone, using an enzyme called 5-alpha reductase. In some follicles, DHT causes them to shrink a little more with every hair growth cycle. The follicle doesn't die, it just keeps producing thinner, finer hair each time, until eventually it's barely producing anything visible.
So why does it look so different in men and women, if it's the same hormone?
A study from 1997 looked at scalp biopsies from 12 men and 12 women with pattern hair loss, and found two things:
- Women had roughly half the DHT-related activity at the hairline that men did
- Women also had much higher levels of an enzyme that converts testosterone into estrogen instead, meaning less of it turns into DHT in the first place
Basically: women's hairlines are naturally better protected from this whole process. That's the leading theory, anyway; it was a small study (24 people), so it's a strong lead, not a proven fact. This is also why doctors have started saying "female pattern hair loss" instead of "female androgenetic alopecia"; the second term claims more certainty than we actually have.
The cause that gets missed: PCOS
Here's the part most hair-loss content skips entirely.
PCOS (polycystic ovary syndrome) is the most common hormonal condition in women of reproductive age, affecting somewhere between 6-15% of women. It can cause the ovaries to produce excess androgens, and those excess androgens can drive the same DHT-related follicle shrinking described above, showing up as classic female pattern thinning: widening part, thinner strands, hairline usually intact.
One honest caveat worth including, because a hair-loss brand should say this rather than bury it: the actual relationship between androgen levels and this hair loss pattern is genuinely inconsistent. A number of affected women have completely normal circulating androgen levels, and the hair loss shows up anyway, likely because local sensitivity at the follicle matters as much as the amount of hormone circulating in blood. So PCOS is a major, common contributor, not an automatic explanation for every case, and separately, insulin resistance and metabolic syndrome (which often travel with PCOS but can also occur without it) have their own independent link to this same pattern of hair thinning.
If you also have irregular periods, acne along the jawline, or unusual hair growth on the face or body, that combination is worth raising with a doctor specifically in the context of PCOS, rather than only treating the hair loss in isolation.
Why women often don't notice until it's advanced
Men's hair loss is hard to miss; it's right there in the mirror. Women's version is sneakier:
- It thins evenly, so there's no obvious "line" to notice
- Shedding usually starts long before you can actually see less hair
- It's easy to blame on something else: stress, water, a bad haircut, being unwell
- Several other conditions look almost identical: thyroid issues, telogen effluvium (stress-shedding after illness, surgery, or childbirth), low ferritin, and PCOS itself, often for years before anyone connects the dots
These all need a proper diagnosis, not a guess. The earlier it's caught, the easier it is to actually influence.
What a scalp serum can (and can't) do
Being straight about this: certain actives genuinely do help. Ingredients like Redensyl have real published data behind them: meaningful reductions in shedding, measurable improvement in the ratio of growing to resting follicles. That's not marketing spin; it's a documented effect.
What a serum still can't do is reverse the underlying hormonal or genetic driver the way a prescription anti-androgen can, or undo years of established miniaturisation on its own. And if the real cause is PCOS, thyroid dysfunction, or low ferritin, a scalp serum is treating a downstream symptom while the actual driver goes unaddressed.
What a good scalp serum reliably does is keep the environment around your follicles healthy, with less buildup, a calmer barrier, and less inflammation, while also delivering actives shown to support shedding reduction and density. That's real; it's just not the whole picture if there's an underlying hormonal cause still active.
That's the honest role Scalp Snack plays: meaningful scalp-level support, alongside proper diagnosis and medical advice where needed, not instead of it.
The bottom line
Same hormone family, same basic mechanism, very different-looking outcomes between men and women, and for a real share of women, an additional, commonly-missed driver in PCOS.
If your parting's been looking wider, or shedding's been heavier than usual, that's worth getting checked, including asking specifically about PCOS if you have any of the other signs. Not "someday." Now, while it's easier to actually do something about it.
Sources: Sawaya & Price, 1997 (Journal of Investigative Dermatology); Ludwig, 1977 (British Journal of Dermatology); Norwood, 1975 (Southern Medical Journal); Olsen, 2001 (Journal of the American Academy of Dermatology); Azziz et al., Female Pattern Hair Loss and Androgen Excess, Androgen Excess and PCOS Society Report, Journal of Clinical Endocrinology & Metabolism, 2019; Reddy et al., Metabolic Syndrome in Premenopausal Women with FPHL, Cureus, 2024